Frontline myeloma therapy lands on the PBS

4 minute read


The monoclonal antibody becomes Australia’s first new frontline treatment in over a decade for patients ineligible for transplant.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×